Circular Genomics

Are you feeling the holiday blues? Many people report feeling anxious and depressed during the holidays . A survey by the American Psychological Association found that 38% of people feel more stressed during this season. This added stress can lead to increased risks of illness, substance misuse, and higher rates of anxiety and depression. If you or someone you love is struggling, remember that help is available. Reach out to a mental health professional or check out our patient resources for support —because no one should have to face this season alone. 💙 Patient Resources: https://hubs.la/Q02_Rpvq0 #HolidayBlues #MentalHealthMatters #YouAreNotAlone

Hot News🔥 Announcing Cohort 8 featuring 7 high-growth startups joining Scale Up Greece by Endeavor! 👏 Welcome Acumino, Circular Genomics, Cinobo, EVO Human Performance, Threedium, Triparound, and YourHero/Douleutaras to the program 🎉 We’re beyond excited to work with Cohort VIII’s game-changing founders who are redefining industries and strengthening Greece’s position as an innovation hub. 💡 A little bit about Cohort 8: 💰 Raised over $50M USD 💼 Created 242 jobs globally 🌍 Present in 6 markets, including Athens, San Francisco, New Mexico, and London 👀 Representing sectors like Robotics/AI, Life Sciences, Sportstech, Traveltech, Entertainment, and Consumer Tech. With open arms, we welcome you to our thriving community of over 70 rapidly scaling companies 🤝. For more information, check out our blog here: https://lnkd.in/dv-azPAy #endeavorgr #greektech #scaleup #innovation #entrepreneurship

💡 What is the MindLight™ Antidepressant Response Test? Watch this quick clip to discover how our brain-derived biomarker test works and how it can support both patients and physicians in creating personalized treatment plans. #MindLightTest #PersonalizedMedicine #MentalHealth #CircularGenomics #Innovation #Antidepressants

ICYMI: Catch up on our latest video showcasing the MindLight™ Antidepressant Response Test can help stratify patients struggling with depression. Learn how genomic insights from circular RNA are shaping personalized SSRI treatments and improving personalized care. Watch here: https://hubs.la/Q02_R54t0

We're excited to share that our Marketing Director, Adebanke (Banke) Fagbemi, Ph.D., was featured on Dr. Bolanle Akinronbi MD's BrightMindsMD Podcast! In this episode, they discuss the important question: "How Do I Know My Antidepressants Are Working?" Discover insights on the latest advancements in personalized medicine and how innovative tools like the MindLight™ Antidepressant Response Test are transforming mental health care. 🎧 Tune in on Spotify and Youtube: Spotify: https://lnkd.in/gnBn-gJT YouTube: https://lnkd.in/gSv9UwNG #MentalHealth #BrightMindMD #CircularGenomics #PersonalizedMedicine #MindLightTest #Antidepressants

Have you or a loved one recently been diagnosed with major depressive disorder? Learn more about how Circular Genomic's MindLight Antidepressant Response Test™ can help you and your doctor make the right treatment decisions for your unique case of depression. Visit our website to learn more: https://lnkd.in/g4qZaKZP

Did you know that SSRIs only work for 41% of patients? This means the majority of people with #depression fail to respond to the standard first line of treatment, with HCPs using educated guessing to finding the right treatment. The MindLight Antidepressant Response Test™ can improve the standard of care in depression management by predicting a patient's likelihood of response to SSRIs and help physicians to create personalized treatment plans from the start. Learn more: https://hubs.la/Q02_ggzP0

MindLight™ has been featured in Digital Health Buzz! The article highlights how our innovative diagnostic test is transforming care for patients with Major Depressive Disorder. By analyzing circular RNA through a simple blood draw, MindLight™ empowers healthcare providers with personalized insights to predict antidepressant response, reducing trial-and-error treatment. Read the full feature and discover how MindLight™ is shaping the future of precision medicine in mental health care. Check it out here: https://hubs.la/Q02-JZR90 #MindLightTest #MentalHealthInnovation #PrecisionMedicine #MajorDepressiveDisorder

We’re excited to share that our CEO, Paul Sargeant, PhD, will be speaking at the Dubai Family Office Investment Summit on December 12th, hosted by Epicon Capital Club! This event will feature a dynamic lineup of discussions on Emerging Trends and Transformative Ideas, bringing together visionary leaders to shape the future of investment. At Circular Genomics, we are dedicated to enhancing patient lives and revolutionizing mental health management worldwide through innovation and precision medicine. Paul will highlight how our vision aligns with the forward-thinking conversations driving the future of healthcare and beyond.

Finding the right antidepressant can feel like trial and error—but it doesn’t have to be. MindLight™ uses the power of your unique genomic makeup to predict how you might respond to different SSRIs, helping your healthcare provider make informed decisions about your treatment plan. 🧪 How it works: A simple blood draw analyzes your circular RNA, providing actionable insights to guide personalized care. 💡 Why it matters: - Faster path to the right treatment - Fewer side effects - A personalized approach to mental health care With MindLight™, precision medicine meets mental health, empowering patients and providers to navigate major depressive disorder with confidence. Learn more about how MindLight™ is transforming care at https://hubs.ly/Q02-8QH70!